Fluid stewardship in intensive care: clinical pharmacist’s actions analysis
DOI:
https://doi.org/10.30968/rbfhss.2024.153.1135Abstract
Objective: To describe and analyze the pharmaceutical interventions performed by clinical intensivist pharmacists in the management of fluid therapy. Methods: This is an observational, retrospective, descriptive study conducted in a clinical ICU of a tertiary teaching hospital from January 2018 to December 2022. The study evaluated the classification according to the “four rights of fluid therapy” adapted from Hawkins14 (right drug, right dose, right route, and right patient); the acceptability of pharmaceutical interventions; the classification of interventions involving hidden fluids, and the medications involved in this classification. Results: The study included 415 patients, the majority of whom were male, 51% (213). The mean age was 57.4 ± 17.2 years. A total of 993 pharmaceutical interventions related to fluids were performed, comprising 12.2% of the interventions during the study period and corresponding to 2.4 per patient. The acceptability rate was 90% (894). Of the cited interventions, the majority (591) were related to the “right dose” (59.4%). The other interventions were: 167 (16.9%) related to the “right drug,” 163 (16.4%) to the “right route,” and 72 (7.2%) to the “right patient.” The management of hidden fluids was present in 722 (72.7%) interventions, with a focus on antimicrobials, totaling 256 (35.4%); followed by electrolytes and vitamins with 229 (31.7%), and antiulcer agents with 124 (17.2%). Conclusion: The pharmaceutical interventions analyzed were related to the “four rights of fluid therapy” and had high acceptability from the team. There was significant demand for pharmaceutical intervention in fluid management. The findings indicate the potential role of the clinical intensivist pharmacist as a key player in the fluid therapy management of critically ill patients.
Downloads
References
Hoste EA, Maitland K, Brudney CS, et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth.2014;113(5):740-7. DOI: 10.1093/bja/aeu300.
Kelm DJ, Perrin JT, Cartin-Ceba R, et al. Fluid overload in patients with severe sepsis and septic shock treated with early goal-directed therapy is associated with increased acute need for fluid-related medical interventions and hospital death. Shock. 2015;43(1):68-73. DOI: 10.1097/SHK.0000000000000268.
Mitchell KH, Carlbom D, Caldwell E, et al. Volume overload: prevalence, risk factors, and functional outcome in survivors of septic shock. Ann Am Thorac Soc. 2015;12(12):1837-44. DOI: 10.1513/AnnalsATS.201504-187OC.
Vaara ST, Korhonen AM, Kaukonen KM, et al. Fluid overload is associated with an increased risk for 90-day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 2012;16(5):R197. DOI: 10.1186/cc11682.
Brotfain E, Koyfman L, Toledano R, et al. Positive fluid balance as a major predictor of clinical outcome of patients with sepsis/septic shock after ICU discharge. Am J Emerg Med. 2016;34(11):2122-2126. DOI: 10.1016/j.ajem.2016.07.058.
Claure-Del Granado R, Mehta RL. Fluid overload in the ICU: evaluation and management. BMC Nephrol. 2016;17(1):109. DOI: 10.1186/s12882-016-0323-6.
Malbrain ML, Marik PE, Witters I, et al. Fluid overload, de resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther. 2014;46(5):361-80. DOI: 10.5603/AIT.2014.0060.
Jozwiak M, Silva S, Persichini R, et al. Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome. Crit Care Med. 2013;41(2):472-80. DOI: 10.1097/CCM.0b013e31826ab377.
Sakr Y, Rubatto Birri PN, Kotfis K, et al. Higher Fluid Balance Increases the Risk of Death From Sepsis: Results From a Large International Audit. Crit Care Med. 2017;45(3):386-394. DOI: 10.1097/CCM.0000000000002189.
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344-53. DOI: 10.1097/01.ccm.0000194725.48928.3a.
Branan T, Smith SE, Newsome AS, et al. Association of hidden fluid administration with development of fluid overload reveals opportunities for targeted fluid minimization. SAGE Open Med. 2020;8:2050312120979464. DOI: 10.1177/2050312120979464.
Gamble KC, Smith SE, Bland CM, et al. Hidden Fluids in Plain Sight: Identifying Intravenous Medication Classes as Contributors to Intensive Care Unit Fluid Intake. Hosp Pharm. 2022;57(2):230-236. DOI: 10.1177/00185787211016339.
Van Regenmortel N, Verbrugghe W, Roelant E, et al. Maintenance fluid therapy and fluid creep impose more significant fluid, sodium, and chloride burdens than resuscitation fluids in critically ill patients: a retrospective study in a tertiary mixed ICU population. Intensive Care Med. 2018;44(4):409-417. DOI: 10.1007/s00134-018-5147-3.
Hawkins WA, Smith SE, Newsome AS, et al. Fluid Stewardship During Critical Illness: A Call to Action. J Pharm Pract. 2020;33(6):863-873. DOI: 10.1177/0897190019853979.
Lee H, Ryu K, Sohn Y, et al. Impact on Patient Outcomes of Pharmacist Participation in Multidisciplinary Critical Care Teams: A Systematic Review and Meta-Analysis. Crit Care Med. 2019;47(9):1243-1250. DOIi: 10.1097/CCM.0000000000003830.
Hawkins WA, Butler SA, Poirier N, et al. From theory to bedside: Implementation of fluid stewardship in a medical ICU pharmacy practice. Am J Health Syst Pharm. 2022;79(12):984-992. DOI: 10.1093/ajhp/zxab453.
Dos Santos Melo MS, Pereira V, Nascimento LS, Rodrigues JLG. (2021). Importância do serviço de revisão da farmacoterapia no home care: uma revisão narrativa. Revista Artigos. Com. 2021;32, e9381.
De Consenso, C. Segundo consenso de Granada sobre problemas relacionados con medicamentos. Ars Pharmaceutica (Internet). 2002;43(3-4), 179-187.
Perez M, Masse M, Deldicque A, et al. Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital. Eur J Hosp Pharm. 2022;29(e1):e30-e35. DOI: 10.1136/ejhpharm-2020-002542.
Wang R, Kong L, Xu Q, et al. On-ward participation of clinical pharmacists in a Chinese intensive care unit for patients with COVID-19: A retrospective, observational study. Res Social Adm Pharm. 2021;17(1):1853-1858. DOI: 10.1016/j.sapharm.2020.06.005.
Lima IM, Vidigal SB, Lima NM, et al. Application of FASTHUG-MAIDENS mnemonic and evaluation of its impact in pharmaceutical intervention in an adult intensive care unit. Rev Bras Farm Hosp Serv Saude. 2021;12(1):0566. DOI: 10.30968/rbfhss.2021.121.0566.
Richter A, Bates I, Thacker M, et al. Impact of the introduction of a specialist critical care pharmacist on the level of pharmaceutical care provided to the critical care unit. Int J Pharm Pract. 2016;24(4):253-61. DOI: 10.1111/ijpp.12243.
Hermes VC, Loureiro AP, Assis MP, et al. Pharmacoeconomic and antimicrobial stewardship analysis in waste management: Beyond switching drug administration route. Am J Infect Control. 2023;51(12):1334-1338. DOI: 10.1016/j.ajic.2023.06.003.
Parente DM, Morton J. Role of the Pharmacist in Antimicrobial Stewardship. Med Clin North Am. 2018;102(5):929-936. DOI: 10.1016/j.mcna.2018.05.009.
Araújo EO, Viapiana M, Domingues EAM, et al. Intervenções Farmacêuticas em uma Unidade de Terapia Intensiva de um Hospital Universitário. Rev. Bras. Farm. Hosp. Serv. Saúde. 2017;8(3):25-30. DOI: 10.30968/rbfhss.2017.083.005.
Fideles GM, Alcântara-Neto JM, Peixoto Júnior AA, et al. Pharmacist recommendations in an intensive care unit: three-year clinical activities. Rev Bras Ter Intensiva. 2015;27(2):149-54. DOI: 10.5935/0103-507X.20150026.
Almeida NRC, Pontes GF, Jacob FL, et al. Analysis of trends in sepsis mortality in Brazil and by regions from 2010 to 2019. Rev Saude Publica. 2022;56:25. DOI: 10.11606/s1518-8787.2022056003789.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Serlf-archiving policy
This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.
